Chitosan and silver nanoparticles: promising anti-toxoplasma agents
- PMID: 24852215
- DOI: 10.1016/j.exppara.2014.05.005
Chitosan and silver nanoparticles: promising anti-toxoplasma agents
Abstract
Toxoplasmosis is a worldwide infection caused by obligate intracellular protozoan parasite which is Toxoplasma gondii. Chitosan and silver nanoparticles were synthesized to be evaluated singly or combined for their anti-toxoplasma effects as prophylaxis and as treatment in the experimental animals. Results were assessed through studying the parasite density and the ultrastructural parasite changes, and estimation of serum gamma interferon. Weight of tissue silver was assessed in different organs. Results showed that silver nanoparticles used singly or combined with chitosan have promising anti-toxoplasma potentials. The animals that received these compounds showed statistically significant decrease in the mean number of the parasite count in the liver and the spleen, when compared to the corresponding control group. Light microscopic examination of the peritoneal exudates of animals receiving these compounds showed stoppage of movement and deformity in shape of the tachyzoites, whereas, by scanning electron microscope, the organisms were mutilated. Moreover, gamma interferon was increased in the serum of animals receiving these compounds. All values of silver detected in different tissues were within the safe range. Thus, these nanoparticles proved their effectiveness against the experimental Toxoplasma infection.
Keywords: Chitosan nanoparticles; Silver nanoparticles; Toxoplasmosis.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Silver nanoparticles as a therapeutic agent in experimental cyclosporiasis.Exp Parasitol. 2019 Dec;207:107772. doi: 10.1016/j.exppara.2019.107772. Epub 2019 Oct 11. Exp Parasitol. 2019. PMID: 31610183
-
Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.Exp Parasitol. 2019 Sep;204:107717. doi: 10.1016/j.exppara.2019.107717. Epub 2019 Jun 20. Exp Parasitol. 2019. PMID: 31228418
-
Effect of Nigella sativa oil on experimental toxoplasmosis.Parasitol Res. 2016 Jan;115(1):379-90. doi: 10.1007/s00436-015-4759-6. Epub 2015 Oct 7. Parasitol Res. 2016. PMID: 26446086
-
[New pathogens and mode of action of azithromycin: Toxoplasma gondii].Pathol Biol (Paris). 1995 Jun;43(6):561-4. Pathol Biol (Paris). 1995. PMID: 8539083 Review. French.
-
Screening for small molecule inhibitors of Toxoplasma gondii.Expert Opin Drug Discov. 2012 Dec;7(12):1193-206. doi: 10.1517/17460441.2012.729036. Epub 2012 Sep 24. Expert Opin Drug Discov. 2012. PMID: 22998671 Review.
Cited by
-
High Efficacy of Green Synthesized Silver Nanoparticles for Treatment of Toxoplasma Gondii Infection Through Their Immunomodulatory, Anti-Inflammatory, and Antioxidant Potency.Acta Parasitol. 2024 Jun;69(2):1201-1211. doi: 10.1007/s11686-024-00845-8. Epub 2024 Apr 18. Acta Parasitol. 2024. PMID: 38634986
-
A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).Front Microbiol. 2017 Jan 20;8:25. doi: 10.3389/fmicb.2017.00025. eCollection 2017. Front Microbiol. 2017. PMID: 28163699 Free PMC article. Review.
-
Anticoccidial activities of Chitosan on Eimeria papillata-infected mice.Parasitol Res. 2016 Jul;115(7):2845-52. doi: 10.1007/s00436-016-5035-0. Epub 2016 Apr 4. Parasitol Res. 2016. PMID: 27041340
-
Pathogen-binding nanoparticles to inhibit host cell infection by heparan sulfate and sialic acid dependent viruses and protozoan parasites.Smart Med. 2024 Mar 1;3(2):e20230046. doi: 10.1002/SMMD.20230046. eCollection 2024 Jun. Smart Med. 2024. PMID: 39188697 Free PMC article. Review.
-
Nanomaterials as a Potential Target for Infectious Parasitic Agents.Curr Drug Deliv. 2024;21(6):828-851. doi: 10.2174/1567201820666230223085403. Curr Drug Deliv. 2024. PMID: 36815647 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical